After adjusting for age, we found that patients with high level of serum Apo-A1 were shown to have marginally significant higher odds of small tumor size relative to patients with lower level of serum Apo-A1, OR and 95% CI 0.514 (0.204–1.292).
← all excerpts
Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China.
1
—
—